Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more infromation

Click here to sign up for SAGE Journal Email Alerts today!

Nutrition in Clinical Practice
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hughes, C.
Right arrow Articles by Ferrone, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hughes, C.
Right arrow Articles by Ferrone, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Current Literature

Differential Effect of Weight Loss on Insulin Resistance in Surgically Treated Obese Patients

Caren Hughes, PharmD and Marcus Ferrone, PharmD, MS

Purpose: To compare the effects of equivalent weight loss induced by two bariatric surgical techniques on insulin action in severely obese patients. Methods: Eighteen nondiabetic patients with severe obesity (mean [± SD] body mass index: 53.5 ± 9 kg/m2) and 20 sex- and age-matched lean subjects (body mass index: 23.8 ± 3 kg/m2) underwent metabolic studies, including measurement of insulin sensitivity by the insulin clamp technique. Patients then underwent either vertical banded gastroplasty with Roux-en-Y gastric bypass or biliopancreatic diversion and were restudied at 5–6 months and again at 16–24 months postsurgery. Results: At baseline, patients were hyperinsulinemic (194 ± 47 pmol/L vs 55 ± 25 pmol/L, p < .0001), hypertriglyceridemic (1.56 ± 0.30 mmol/L vs 0.78 ± 0.32 mmol/L, p < .0001), and profoundly insulin resistant (insulin-mediated glucose disposal: 20.8 ± 4.4 µmol/min/kg fat-free mass vs 52 ± 10.1 µmol/min/kg, p < .0001) as compared with controls. Weight loss by the 2 procedures was equivalent in both amount (averaging –53 kg) and time course. In the gastric bypass group, insulin sensitivity improved (23.8 ± 6 µmol/min/kg at 5 months and 33.7 ± 11.3 µmol/min/kg at 16 months, p < .01 vs baseline and controls). In contrast, in the biliopancreatic diversion group, insulin sensitivity was normalized already at 6 months (52.5 ± 12.4 µmol/min/kg, p = .72 vs controls) and increased further at 24 months (68.7 ± 9.5 µmol/min/kg, p < .01 vs controls), despite a persistent obese phenotype (body mass index 33.2 ± 8 kg/m2). Conclusions: In surgically treated obese patients, insulin sensitivity improves in proportion to weight loss with use of predominantly restrictive procedures (gastric bypass) but is reversed completely by predominantly malabsorptive approaches (biliopancreatic diversion) long before normalization of body weight. Selective nutrient absorption and gut hormones may interact with one another in the genesis of the metabolic abnormalities of obesity.

Nutrition in Clinical Practice, Vol. 21, No. 1, 92-93 (2006)
DOI: 10.1177/011542650602100192


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?